Rocket Pharmaceuticals, Inc. (RCKT)
2.565
-0.06
(-2.47%)
USD |
NASDAQ |
Oct 09, 16:00
2.59
+0.02
(+0.97%)
After-Hours: 20:00
Rocket Pharmaceuticals EPS Diluted (Quarterly) : 1.076 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.076 |
| March 31, 2026 | -0.4244 |
| December 31, 2025 | -0.3805 |
| September 30, 2025 | -0.4511 |
| June 30, 2025 | -0.6208 |
| March 31, 2025 | -0.5571 |
| December 31, 2024 | -0.6186 |
| September 30, 2024 | -0.7086 |
| June 30, 2024 | -0.7429 |
| March 31, 2024 | -0.6633 |
| December 31, 2023 | -0.6392 |
| September 30, 2023 | -0.7491 |
| June 30, 2023 | -0.8164 |
| March 31, 2023 | -0.7342 |
| December 31, 2022 | -0.9154 |
| September 30, 2022 | -0.8722 |
| June 30, 2022 | -0.8309 |
| March 31, 2022 | -0.6663 |
| December 31, 2021 | -0.6863 |
| September 30, 2021 | -0.7852 |
| June 30, 2021 | -0.5475 |
| March 31, 2021 | -0.6525 |
| December 31, 2020 | -1.08 |
| September 30, 2020 | -0.5269 |
| June 30, 2020 | -0.454 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.4494 |
| December 31, 2019 | -0.3878 |
| September 30, 2019 | -0.3829 |
| June 30, 2019 | -0.3792 |
| March 31, 2019 | -0.4311 |
| December 31, 2018 | -0.6553 |
| September 30, 2018 | -0.4032 |
| June 30, 2018 | -0.3993 |
| March 31, 2018 | -0.4246 |
| December 31, 2017 | -3.917 |
| September 30, 2017 | -3.957 |
| June 30, 2017 | -1.96 |
| March 31, 2017 | -1.576 |
| December 31, 2016 | -1.92 |
| September 30, 2016 | -1.64 |
| June 30, 2016 | -1.32 |
| March 31, 2016 | -1.52 |
| December 31, 2015 | -1.237 |
| September 30, 2015 | -9.92 |
| June 30, 2015 | -0.60 |
| March 31, 2015 | -0.84 |
| December 31, 2014 | -0.779 |
| September 30, 2014 | -0.8257 |
| June 30, 2014 | -0.9516 |
| March 31, 2014 | -0.7695 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 123.21M |
| Total Expenses (Quarterly) | -123.21M |
| Enterprise Value | 29.14M |
| Earnings Yield | -7.02% |
| Normalized Earnings Yield | -7.025 |